Navigation Links
Baylor Research Institute Receives Multi-Million Dollar Grant To Develop Flu Vaccine
Date:5/13/2009

NIH Grant will also Fund Research of Advanced Technologies for Early Disease Detection

DALLAS, May 13 /PRNewswire-USNewswire/ -- Scientists at Baylor Institute for Immunology Research (BIIR) in Dallas, part of Baylor Research Institute (BRI) and the Baylor Health Care System, announced today that they received a renewal of a multi-million dollar grant from the National Institutes of Health (NIH) to design new vaccines to prevent influenza - including swine flu (H1N1). The grant will also help BRI develop advanced technologies that could be used for early detection of many other diseases, such as cancer, autoimmune diseases and infectious diseases.

This research has been supported for the past six years by the National Institute of Allergy and Infectious Diseases (NIAID), a department of the NIH. The original grant, received in 2003, totaled $16.5 million and has just been renewed by the NIAID for another five years at close to $14 million.

"We have made great progress over the past six years because of this grant. We now know that certain types of immune system cells are better for inducing immunity to the flu. We also know how to target them with molecules that we have developed at BRI," says Jacques Banchereau, Ph.D., director, Baylor Institute for Immunology Research. "With the new funding from the NIAID, we plan to further characterize our targeting molecules and continue to measure the immune response to the flu. This will prepare us for a clinical trial to test our new vaccine."

Additionally, BRI scientists have applied for a supplement to the grant that would allow them to specifically make a vaccine against swine flu. It would also fund studies researching how swine flu affects the immune systems of patients.

"There is serious concern throughout the world health communities about the dangers of emerging infectious diseases, like this new flu strain," says Dr. Banchereau. "Our flu research has focused on finding out how the immune system responds to the flu and on developing a new type of vaccine that will activate a strong protection against the flu."

To develop this vaccine, the researchers will target dendritic cells, key immune system cells that instruct the rest of the immune system to develop immunity against invading microbes.

Another project at BRI has expanded into a new Center for Personalized Medicine led by Damien Chaussabel, Ph.D., a scientist at BIIR. This new center is using microarray technology to measure the expression of over 45,000 genes from a single tube of a patient's blood. What they have found is that the immune system responds in unique ways to different kinds of diseases. This allows the researchers to identify a "biosignature," which can be used to diagnose diseases. This technology might one day be used in doctors' offices and hospitals to diagnose swine flu and other diseases.

"The work being carried out at BRI has the potential to transform the way that we treat patients and diagnose diseases, including those infected with swine flu," says Michael Ramsay, M.D., president, Baylor Research Institute.

Dallas-based Baylor Research Institute, an affiliate of Baylor Health Care System, promotes research that brings innovative treatments from the laboratory to the patient bedside. The Institute focuses on basic and translational science, clinical trials, health care effectiveness and quality of care research. Currently, investigators at Baylor are conducting 800 active research protocols spanning more than 20 medical specialties. Opened in 1996, Baylor Institute for Immunology Research, a component of BRI, focuses on developing new therapies to treat conditions that involve the immune system such as cancer, autoimmune diseases, infectious diseases and organ transplantation.

For more information about the Baylor Research Institute, visit www.BaylorHealth.com. For more information about BIIR, visit www.BIIR.org.


'/>"/>
SOURCE Baylor Health Care System
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Baylor Dallas Nationally Recognized for Nursing Excellence
2. Bill Lively Joins Baylor Health Care System Foundation as Senior Strategic Development Consultant
3. Bernard Brigonnet Joins Baylor Research Institute as Vice President and Chief Operating Officer
4. Evelyn Y. Davis, Shareholder Advocate, and the Evelyn Y. Davis Foundation Donate $100,000 to Riggs Emergency Department at Baylor University Medical Center at Dallas
5. National Quality Forum Names Baylor Health Care System Winner of 2008 NQF National Quality Healthcare Award
6. Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments
7. Baylor Health Care System Receives National Information Technology Recognition
8. Genomic Health to Present at JMP Securities Research Conference
9. Rigel to Present at JMP Securities Research Conference
10. KLRI Releases 3rd Annual Report On Years Top Longevity Research Findings
11. Participants in antidepressant drug trials are atypical patients, UT Southwestern researchers report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology: